A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a ...

Novo Nordisk has stopped two trials of a drug that aims to tame inflammation as a way to improve cardiovascular health, ...

Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...

Analysts say private deals involve drugmakers agreeing to lower prices in Medicaid, where prices are low, in return for no ...

Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study ...

The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...

An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...

The American Diabetes Association “continues to move from crisis to crisis to crisis,” says one of five members ejected from ...

Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for ...